Drugs / Monovalent influenza virus vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00873912 | May 2009 | — | MedImmune LLC | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Monovalent influenza virus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00873912 ↗ |
| Modality | Vaccine | “monovalent influenza virus vaccine” NCT00873912 ↗ |
| Route | Intranasal | “receive a single dose of monovalent vaccine or placebo by intranasal spray” NCT00873912 ↗ |